Medicine & Life Sciences
Breast Neoplasms
100%
1,2-di-(4-sulfamidophenyl)-4-butylpyrazolidine-3,5-dione
42%
Mutation
34%
Germ-Line Mutation
26%
Genes
24%
Genetic Testing
23%
Risk Assessment
21%
Manufacturing and Industrial Facilities
16%
Costs and Cost Analysis
16%
Neoplasm Genes
15%
Poly(ADP-ribose) Polymerase Inhibitors
15%
Cyclins
14%
Drug Therapy
13%
Penetrance
13%
Health Personnel
12%
Precision Medicine
12%
Drive
11%
Genetic Predisposition to Disease
11%
High-Throughput Nucleotide Sequencing
11%
Pancreatic Neoplasms
10%
Sensitivity and Specificity
10%
Ovarian Neoplasms
10%
Research Personnel
10%
Blood Cells
9%
Prostatic Neoplasms
9%
Registries
9%
Phenotype
8%
Technology
7%
Neoplasms
7%